Biopsy‐proven residual cervical cancer at the end of combined chemoradiation predicts poor outcome—Retrospective single‐center cohort study

Abstract Introduction Persistent tumor after combined chemoradiation for locally advanced cervical cancer is an established prognostic factor. Detection may include magnetic resonance imaging, positron emission tomography (PET) combined with CT scan, ultrasound, or biopsies; however, no agreement ab...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Christoph Ebner, Ricarda Purtscheller, Barin Feroz, Jana Rieker, Linda Ebner, Mara Mantovan, Sergej Skvortsov, Mario Brüggl, Katharina Leitner, Verena Wieser, Irina Tsibulak, Christian Marth, Alain Gustave Zeimet
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2026-02-01
Colecção:	Acta Obstetricia et Gynecologica Scandinavica
Assuntos:	biopsy cervical cancer chemoradiation follow‐up persistence radiotherapy
Acesso em linha:	https://doi.org/10.1111/aogs.70106
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!